drugset / Trial / NCT01688921

Jet Injection for Influenza

NCT01688921

Phase 4 Completed 1250 enrolled PharmaJet, Inc.
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine if the administration of a seasonal flu vaccine using a PharmaJet's needle-free injection device (STRATIS) is equivalent to needle and syringe administration, as measured by laboratory tests of immune response.

Timeline

Start
2012-10
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Afluria Vaccine 0.5 ml Intramuscular

Indications